Combined Effects of Transcutaneous Electrical Diaphragmatic Stimulation With ACBT'S in Copd
Combined Effects of Transcutaneous Electrical Diaphragmatic Stimulation With ACBT's in COPD
Riphah International University
50 participants
May 28, 2025
INTERVENTIONAL
Conditions
Summary
The combined effects of transcutaneous electrical diaphragmatic stimulation (TEDS) and active cycle of breathing techniques (ACBTs) in patients with chronic obstructive pulmonary disease (COPD) conducted as a randomized controlled trial at Gulab Devi Hospital, the study involved 50 participants aged 40 to 60 with mild to moderate COPD. Participants were divided into two groups, one receiving both TEDS and ACBT, and the other receiving only ACBT. Over 12 weeks, improvements in lung function, oxygen saturation, exercise capacity, and quality of life were measured using spirometry, pulse oximetry, the 6-minute walk test, and the St. George's Respiratory Questionnaire. Both groups showed significant improvement, but the group receiving ACBT alone showed a slightly higher mean rank in some outcomes. The study concludes that while both interventions are beneficial, ACBT alone may offer more consistent improvements. It recommends including respiratory muscle assessments and combining interventions with education and exercise in future research.
Eligibility
Inclusion Criteria4
- COPD (Mild to Moderate)
- Age: 40-60 years of both genders
- Productive cough for more than 2 months
- Oxygen saturation without Oxygen supply \> 88%
Exclusion Criteria3
- Uncontrolled hypertension
- Cardiac diseases
- Active smokers
Interventions
TEDS was applied using surface electrodes placed over the diaphragm region. The stimulation protocol was set at 50 Hz frequency, 300 μs pulse width, with 6 seconds of stimulation followed by 5 seconds of rest, daily for 12 weeks. It was combined with ACBT sessions.
ACBT sessions included breathing control, thoracic expansion exercises, and forced expiration techniques (huffing). Sessions were performed daily for 12 weeks to aid in secretion clearance and improve lung function.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07079553